Press Releases for 2024
Studies Show Significant Unmet Need in Severe Heart Attack Patients and Cost-Effectiveness of SSO2 Therapy
Tuesday, October 29, 2024 in Chelmsford, Mass.
ZOLL Announces Closing of Acquisition of Select Vyaire Ventilator Product LinesMonday, October 14, 2024 in Chelmsford, Mass.
ZOLL AED Plus Received Approval for AEDs Under the EU Medical Device Regulation (MDR) CertificationWednesday, October 2, 2024 in Chelmsford, Mass.
Pro Football Star Damar Hamlin and ZOLL Medical Launch National Movement to Help Save Lives: New Anything Can Happen. Anyone Can Help.™ Campaign Debunks AED Myths and Empowers HeroesTuesday, October 1, 2024 in Chelmsford, Mass.
ZOLL Enrolls First Patient in Groundbreaking SSCORE Commercial Registry at Minneapolis Heart Institute at Abbott Northwestern Hospital (Minneapolis, MN)Monday, September 23, 2024 in Chelmsford, Mass.
ZOLL and PulsePoint advocate for universally accessible AED registryTuesday, September 17, 2024 in Chelmsford, Mass.
ZOLL announces successful bid to acquire ventilator business from Vyaire MedicalMonday, August 19, 2024 in Chelmsford, Mass.
Late-breaking Analysis From the remedē® System Pivotal Trial Suggests Favorable Outcomes for Heart Failure (HF) Patients With Central Sleep Apnea Receiving Phrenic Nerve StimulationMonday, May 13, 2024 in Chelmsford, Mass.
ZOLL Receives Innovative Technology Contract from Vizient for TherOx SuperSaturated Oxygen (SSO₂) TherapyTuesday, April 2, 2024 in Chelmsford, Mass.
ZOLL Receives FDA Clearance and CE Mark to Expand the Thermogard Platform – All-In-One Core and Surface CoolingMonday, January 23, 2024 in Chelmsford, Mass.
ZOLL Receives FDA Clearance and CE Mark to Expand the Thermogard Platform – All-In-One Core and Surface CoolingMonday, January 8, 2024 in Chelmsford, Mass.
ZOLL one of the first to receive approval for AEDs under the EU Medical Device Regulation (MDR) CertificationThursday, February 8, 2024 in Chelmsford, Mass.